Dupont Capital Management’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,206
Closed -$105K 1495
2022
Q3
$105K Sell
1,206
-3,669
-75% -$385K 0.01% 1017
2022
Q2
$555K Hold
4,875
0.03% 660
2022
Q1
$631K Sell
4,875
-432
-8% -$62.3K 0.03% 675
2021
Q4
$958K Sell
5,307
-3,246
-38% -$563K 0.03% 584
2021
Q3
$1.27M Buy
8,553
+1,518
+22% +$233K 0.04% 464
2021
Q2
$1.06M Sell
7,035
-5,285
-43% -$736K 0.03% 550
2021
Q1
$1.6M Buy
12,320
+1,009
+9% +$129K 0.04% 420
2020
Q4
$1.36M Buy
11,311
+4,224
+60% +$414K 0.03% 448
2020
Q3
$529K Buy
7,087
+2,596
+58% +$180K 0.01% 728
2020
Q2
$317K Sell
4,491
-402
-8% -$27.5K 0.01% 945
2020
Q1
$321K Buy
+4,893
New +$390K 0.01% 834

Other funds holding OMCL

Dupont Capital Management's OMCL Position: Q4 2022 in Review

Dupont Capital Management sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 1,206 shares — an estimated $105K sold.

Dupont Capital Management first reported a position in OMCL in Q1 2020 and held it in 11 quarters. The position peaked at $1.6M in Q1 2021. 329 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

  • Dupont Capital Management reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
  • Dupont Capital Management sold 1,206 Omnicell shares in Q4 2022, an estimated $105K.
  • Dupont Capital Management first reported a position in Omnicell in Q1 2020 and held it in 11 quarters.
  • Dupont Capital Management's Omnicell position peaked at $1.6M in Q1 2021.
  • 329 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.